Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (17)

2022

  1. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    Histopathology, Vol. 81, Núm. 6, pp. 826-840

2020

  1. A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior

    Scientific Reports, Vol. 10, Núm. 1

  2. CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer

    Translational Lung Cancer Research, Vol. 9, Núm. 4, pp. 1074-1083

  3. Co-loading of finasteride and baicalin in phospholipid vesicles tailored for the treatment of hair disorders

    Nanoscale, Vol. 12, Núm. 30, pp. 16143-16152

  4. Digital image analysis applied to tumor cell proliferation, aggressiveness, and migration-related protein synthesis in neuroblastoma 3d models

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-17

  5. Innovative strategies to treat skin wounds with mangiferin: fabrication of transfersomes modified with glycols and mucin

    Nanomedicine (London, England), Vol. 15, Núm. 17, pp. 1671-1685

  6. Mangiferin glycethosomes as a new potential adjuvant for the treatment of psoriasis

    International Journal of Pharmaceutics, Vol. 573

2019

  1. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial

    Annals of Surgery, Vol. 270, Núm. 5, pp. 738-746

2018

  1. CD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii657

  2. Lymph microvascularization as a prognostic indicator in neuroblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 26157-26170

  3. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

    Cancer Chemotherapy and Pharmacology, Vol. 82, Núm. 6, pp. 935-943

2015

  1. Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells

    Journal of the American Chemical Society, Vol. 137, Núm. 50, pp. 15892-15898

2012

  1. Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: A translational study based on transient coronary occlusion models

    Journal of the American College of Cardiology, Vol. 59, Núm. 18, pp. 1629-1641

2010

  1. Nickel induces intracellular calcium mobilization and pathophysiological responses in human cultured airway epithelial cells

    Chemico-Biological Interactions, Vol. 183, Núm. 1, pp. 25-33

2008

  1. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients

    Journal of Medical Genetics, Vol. 45, Núm. 9, pp. 557-563

2006

  1. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

    Nephrology Dialysis Transplantation, Vol. 21, Núm. 11, pp. 3252-3257

1999

  1. Molecular characterisation of partial chromosome 21 aneuploidies by fluorescent PCR

    Journal of Medical Genetics, Vol. 36, Núm. 9, pp. 694-699